E 1040

Known as: E-1040, E1040 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2003
0519882003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
SCE-2787, a new cephalosporin having a condensed azolium moiety in the 3 position and an aminothiadiazolyl group in the 7 beta… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1992
1992
E1040 showed the most potent activity (MIC for 90% of strains, 6.25 micrograms/ml) among beta-lactams tested against 70 strains… (More)
Is this relevant?
1992
1992
The synthesis and in vitro antibacterial activity of a series of 7-[(Z)-2-aminoaryl-2-oxyiminoacetamido]-3-ammoniomethyl++ +-3… (More)
Is this relevant?
1990
1990
Seven extended-spectrum beta-lactamases related to TEM and four enzymes derived from SHV-1 were transferred to a common… (More)
Is this relevant?
1990
1990
On the basis of preliminary in vitro data, we evaluated E-1040, a new cephalosporin, against 188 cystic fibrosis (CF) sputum… (More)
Is this relevant?
1990
1990
In designing the dosage form, one major factor controlling their physicochemical properties is solid forms of the drug powder… (More)
Is this relevant?
1990
1990
E1040 is a new parenteral cephalosporin with a broad antibacterial spectrum and potent activity against Gram-negative bacteria… (More)
Is this relevant?
1989
1989
The safety and pharmacokinetics of E1040, a new injectable cephem antibiotic, were evaluated in healthy volunteers. In single… (More)
Is this relevant?
1988
1988
The in vitro activity of E-1040 [(6R,7R)-3-[(4-carbamoyl-1-quinuclidinio)methyl]-7-[2-(5-amino-1,2 ,4- thiadiazol-3-yl)-(Z)-2… (More)
Is this relevant?
1988
1988
E1040 is a new parenteral cephalosporin with a broad antibacterial spectrum and potent antipseudomonal activity. The compound was… (More)
Is this relevant?